Resverlogix Corp. (TSE:RVX – Get Free Report) passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$0.10 and traded as low as C$0.10. Resverlogix shares last traded at C$0.10, with a volume of 14,147 shares trading hands.
Resverlogix Stock Up 5.0%
The stock has a 50-day moving average price of C$0.10 and a 200-day moving average price of C$0.11. The company has a debt-to-equity ratio of -10.95, a current ratio of 0.13 and a quick ratio of 0.04. The company has a market capitalization of C$30.17 million, a P/E ratio of -3.50 and a beta of 0.69.
Resverlogix (TSE:RVX – Get Free Report) last released its quarterly earnings results on Thursday, November 13th. The biotechnology company reported C$0.00 earnings per share (EPS) for the quarter. On average, research analysts predict that Resverlogix Corp. will post -0.22 EPS for the current fiscal year.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Articles
- Five stocks we like better than Resverlogix
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
